BPC-157 has not been proven safe or effective for any condition and is not eligible for inclusion on the 503B Bulks List for compounding. FDA Review Memorandum, 2023 In other words, BPC157 does not meet FDA standards for legal use in clinical practice
[9] The Current State of Peptide Drug Discovery: Back to the Future
It can help those struggling with these issues to lose weight and keep it off. They also recommend users should implement a reduced-calorie meal plan and increased physical activity while taking the once-weekly medication
But health experts warn that while some patients may like Trumps plan to broaden access, people still need support in getting proper nutrition and exercise
It should not be read as implying compounded preparations carry the branded product's regulatory status or its clinical trial record, which belongs to the approved product alone
2.11 Clinical Study Population and Design Fourteen adults with T2DM from February 2025 to November 2025 were recruited from the Department of Endocrinology, Zhongshan Hospital, Fudan University (Xiamen)